abstract |
The present invention relates to an oligosaccharide sequence that binds to Helicobacter pylori [Gal (A) q (NAc) r / Glc (A) q (NAc) r α3 / β3 s [Galβ4GlcNAcβ3] t Galβ4Glc (NAc) u the pharmaceutical for the treatment of symptoms due to the presence of (, q, r, s, t and u are each independently 0 or 1 in the formula) material or a receptor, to their use, for example, Helicobacter pylori (Helicobacter pylori) containing And its use in nutritional compositions. The present invention also relates to the use of a diagnostic receptor for Helicobacter pylori . |